ProgressImage ProgressImage
Sun Pharmaceutical Industries Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 524715 border-img ISIN Demat INE044A01036 border-img Book Value 101.44 border-img NSE Symbol SUNPHARMA border-img Div & Yield % 0.98 border-img Market Cap ( Cr.) 392567.19 border-img P/E 78.81 border-img EPS 20.76 border-img Face Value 1
ParticularsMar 2025
()
Mar 2024
()
Mar 2023
()
Mar 2022
()
Mar 2021
()
Mar 2020
()
INCOME :       
Sales Turnover 23003.3320275.1720812.1415585.9814116.0512531.93
Excise Duty 0.000.000.000.000.000.00
Net Sales 23003.3320275.1720812.1415585.9814116.0512531.93
Other Income 623.97553.48329.291196.88192.071510.92
Stock Adjustments 69.17-180.32237.93183.18179.64-138.60
Total Income 23696.4720648.3321379.3616966.0414487.7613904.25
EXPENDITURE :       
Raw Materials 6050.205423.796292.095833.575287.124429.12
Power & Fuel Cost 435.72450.42495.21422.33384.16394.74
Employee Cost 2608.262373.952156.952000.781805.981702.77
Other Manufacturing Expenses 1261.721195.301037.321064.32862.12860.05
Selling & Administrative Expenses 5539.894754.864326.423514.053309.621919.25
Miscellaneous Expenses 638.63615.663257.272086.08479.24375.75
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure 16534.4214813.9817565.2614921.1312128.249681.68
Operating Profit 7162.055834.353814.102044.912359.524222.57
Interest 893.21784.08472.18388.10267.52408.01
Gross Profit 6268.845050.273341.921656.812092.003814.56
Depreciation 1238.271600.621600.871349.951236.43561.56
Profit Before Tax 5030.573449.651741.05306.86855.573253.00
Tax 908.62546.10752.77-553.58244.91386.46
Fringe Benefit tax 0.000.000.000.000.000.00
Deferred Tax -160.6745.37-702.44960.43-231.74-344.60
Reported Net Profit 4282.622858.181690.72-99.99842.403211.14
Extraordinary Items 7.08-193.46-2181.63-1263.25-63.64193.27
Adjusted Net Profit 4275.543051.643872.351163.26906.043017.87
Adjustment below Net Profit -11.87-19.867.38-14.532675.94-211.52
P & L Balance brought forward 12731.0412790.8813612.0815964.5514005.2712384.61
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 3613.972898.162519.302237.951559.061378.96
P & L Balance carried down 13387.8212731.0412790.8813612.0815964.5514005.27
Dividend 0.000.000.000.000.000.00
Preference Dividend 0.000.000.000.000.000.00
Equity Dividend % 1600.001350.001150.001000.00750.00400.00
Dividend Per Share(Rs) 16.0013.5011.5010.007.504.00
Earnings Per Share-Unit Curr 17.8511.917.05-0.423.5113.38
Earnings Per Share(Adj)-Unit Curr 17.8511.917.05-0.423.5113.38
Book Value-Unit Curr 101.4598.7698.98102.48112.28101.68
Book Value(Adj)-Unit Curr 101.4598.7698.98102.48112.28101.68

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.  Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......issued in the interest of investors.   KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing.

x
x
×
Let's Chat
close
refresh